|
|
Volumn , Issue , 2009, Pages 247-249
|
|
ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
HYDROXYCHLOROQUINE;
LUPUS ANTICOAGULANT;
ADULT;
BLOOD;
DOUBLE BLIND PROCEDURE;
DRUG COMBINATION;
EVIDENCE BASED MEDICINE;
FEMALE;
HUMAN;
INCIDENTAL FINDING;
PARTIAL THROMBOPLASTIN TIME;
PRACTICE GUIDELINE;
PRIMARY PREVENTION;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
REFERENCE VALUE;
REVIEW;
STANDARD;
THROMBOEMBOLISM;
THROMBOPHILIA;
UNNECESSARY PROCEDURE;
ADULT;
ANTICOAGULANTS;
ASPIRIN;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
EVIDENCE-BASED MEDICINE;
FEMALE;
HUMANS;
HYDROXYCHLOROQUINE;
INCIDENTAL FINDINGS;
LUPUS COAGULATION INHIBITOR;
PARTIAL THROMBOPLASTIN TIME;
PRACTICE GUIDELINES AS TOPIC;
PRIMARY PREVENTION;
PROSPECTIVE STUDIES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
REFERENCE VALUES;
THROMBOEMBOLISM;
THROMBOPHILIA;
UNNECESSARY PROCEDURES;
|
|
EID: 77949483894
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation-2009.1.247 Document Type: Review |
|
Times cited : (21)
|
|
References (15)
|
